Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients.

ABSTRACT:

Objective

To determine how mental disorders and psychopharmacological treatments before and during COVID-19 hospital admissions are related to mortality.

Methods

Subjects included in the study were all adult patients with a diagnosis of COVID-19, confirmed clinically and by PCR, who were admitted to a tertiary university hospital in Badalona (Spain) between March 1 and November 17, 2020. Data were extracted anonymously from computerized clinical records.

Results

2,150 subjects were included, 57% males, mean age 61 years. History of mental disorders was registered in 957 (45%). Throughout admission, de novo diagnosis of mood or anxiety, stress, or adjustment disorder was made in 12% of patients without previous history. Delirium was diagnosed in 10% of cases. 1011 pati

SUBMITTER: Diez-Quevedo C 

PROVIDER: S-EPMC8250711 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature